A discovery at Hudson Institute more than 20 years ago is still sparking new medical insights, with researchers at a major US University using it to uncover vital facts about sexually transmitted disease (STI).
Jul 24, 2025
0
25
Oxidative stress is considered to contribute to the development of cancer. However, a recent study in Japan showed that oxidative stress may suppress rather than cause cancer development in individuals with variants of the ...
Jul 24, 2025
0
0
In a recent paper published in Nature, researchers at the University of Chicago discovered how to block nicotinamide N-methyl transferase (NNMT), an enzyme that is involved in the progression of high-grade serous ovarian ...
Jul 24, 2025
0
20
Research led by Memorial Sloan Kettering Cancer Center (MSK) is shedding new light on how ovarian cancer evolves—insights that could help researchers develop more effective treatment strategies.
Jul 16, 2025
0
21
An unusual DNA structure may hold the key to treating one of the deadliest cancers affecting women, which claims more than 200,000 lives globally each year.
Jul 15, 2025
0
0
People with the rare growth hormone disorder acromegaly have a significantly higher risk of developing various types of cancer, often at ages younger than typically seen in the general population, according to a study presented ...
Jul 15, 2025
0
0
A pairing of two experimental drugs inhibits tumor growth and blocks drug-induced resistance in ovarian cancer, according to a preclinical study led by Weill Cornell Medicine investigators.
Jul 7, 2025
0
42
New research from UC Davis Comprehensive Cancer Center has uncovered an evolutionary change that may explain why certain immune cells in humans are less effective at fighting solid tumors compared to non-human primates. This ...
Jul 3, 2025
0
56
Patients with ovarian clear cell carcinoma (OCCC) whose tumors have specific mutations in the PPP2R1A gene were found to have improved survival following immunotherapy compared to patients without these mutations, according ...
Jul 2, 2025
0
2
Imagine a drug that halts cancer without side effects or risks. That future may be a bit nearer thanks to recent research led by Raj Kumar, Ph.D., chair of the Department of Pharmaceutical and Biomedical Sciences at Touro ...
Jun 26, 2025
0
21
